Burden and causes due to high fasting plasma glucose in China from 1990 to 2021: a systematic analysis and comparison with the global burden
Abstract Objective High fasting plasma glucose (HFPG) is an important global health problem with increased morbidity. There were 1.07 million deaths attributed to HFPG in China in 2019, which accounts for about 16.5% of the global deaths due to HFPG. We aimed to analyze the burden and causes due to...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-01-01
|
| Col·lecció: | BMC Public Health |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12889-025-23115-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
